Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study
Identifieur interne : 002D98 ( Main/Exploration ); précédent : 002D97; suivant : 002D99Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study
Auteurs : Claudio Lucetti [Italie] ; Paulo Del Dotto [Italie] ; Gianna Gambaccini [Italie] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Caterina Berti [Italie] ; Giuseppe Rossi [Italie] ; Maria Cristina Bianchi [Italie] ; Michela Tosetti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-11-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adult, Aged, Aspartic Acid (analogs & derivatives), Aspartic Acid (metabolism), Choline (metabolism), Creatinine (metabolism), Dopamine Agonists (therapeutic use), Dopamine agonist, Female, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Male, Middle Aged, Motor Cortex (drug effects), Motor Cortex (metabolism), Motor Cortex (pathology), Motor cortex, Nervous system diseases, Nuclear magnetic resonance imaging, Parkinson Disease (drug therapy), Parkinson Disease (metabolism), Parkinson Disease (pathology), Parkinson disease, Parkinson's disease, Pergolide, Pergolide (therapeutic use), Protons, Treatment, Treatment Outcome, dopamine agonists, pergolide, spectroscopy.
- MESH :
- chemical , analogs & derivatives : Aspartic Acid.
- chemical , metabolism : Aspartic Acid, Choline, Creatinine.
- chemical , therapeutic use : Dopamine Agonists, Pergolide.
- drug effects : Motor Cortex.
- drug therapy : Parkinson Disease.
- metabolism : Motor Cortex, Parkinson Disease.
- pathology : Motor Cortex, Parkinson Disease.
- Adult, Aged, Female, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Male, Middle Aged, Protons, Treatment Outcome.
Abstract
The objective of this study was to investigate neurochemical and metabolic changes in the motor cortex in a group of de novo Parkinson's disease (PD) patients before and after 6 mo treatment with the dopamine agonist pergolide. Proton magnetic resonance spectroscopy (1H‐MRS) has been used to study striatal and cortical metabolism in PD and other parkinsonisms. So far, no studies evaluating possible brain metabolic changes in PD patients before and after dopaminergic therapy have been reported. De novo PD patients (11) and controls (11) underwent clinical evaluation (UPDRS‐III motor evaluation) and a first single‐voxel 1H‐MRS of the motor cortex. 1H‐MRS studies were performed using the PROBE‐SV System implemented on a 1.5 Tesla Scanner (GE Medical System, Milwaukee, WI). Pergolide was administered up to a dose of 1 mg t.i.d. After 6 mo follow‐up, all patients were clinically evaluated and a second single‐voxel 1H‐MRS was performed. Lower values of Cho/Cr and NAA/Cr ratios were observed in the motor cortex of PD patients compared with controls (P < 0.02 and P < 0.01, respectively). After 6 mo therapy with pergolide (1 mg t.i.d), PD patients showed an improvement in motor performances (P < 0.05) and an increase in Cho/Cr ratios in the motor cortex at the second 1H‐MRS evaluation (P < 0.05) was reported. In conclusion, cortical NAA/Cr and Cho/Cr ratios may be impaired in de novo PD. Dopaminergic therapy capable of improving motor function may restore the Cho/Cr ratio in the motor cortex. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21576
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001398
- to stream Istex, to step Curation: 001398
- to stream Istex, to step Checkpoint: 001906
- to stream PubMed, to step Corpus: 002537
- to stream PubMed, to step Curation: 002537
- to stream PubMed, to step Checkpoint: 002770
- to stream Ncbi, to step Merge: 001E22
- to stream Ncbi, to step Curation: 001E22
- to stream Ncbi, to step Checkpoint: 001E22
- to stream Main, to step Merge: 003D20
- to stream PascalFrancis, to step Corpus: 001460
- to stream PascalFrancis, to step Curation: 001859
- to stream PascalFrancis, to step Checkpoint: 001634
- to stream Main, to step Merge: 004224
- to stream Main, to step Curation: 002D98
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study</title><author><name sortKey="Lucetti, Claudio" sort="Lucetti, Claudio" uniqKey="Lucetti C" first="Claudio" last="Lucetti">Claudio Lucetti</name></author><author><name sortKey="Del Dotto, Paulo" sort="Del Dotto, Paulo" uniqKey="Del Dotto P" first="Paulo" last="Del Dotto">Paulo Del Dotto</name></author><author><name sortKey="Gambaccini, Gianna" sort="Gambaccini, Gianna" uniqKey="Gambaccini G" first="Gianna" last="Gambaccini">Gianna Gambaccini</name></author><author><name sortKey="Ceravolo, Roberto" sort="Ceravolo, Roberto" uniqKey="Ceravolo R" first="Roberto" last="Ceravolo">Roberto Ceravolo</name></author><author><name sortKey="Logi, Chiara" sort="Logi, Chiara" uniqKey="Logi C" first="Chiara" last="Logi">Chiara Logi</name></author><author><name sortKey="Berti, Caterina" sort="Berti, Caterina" uniqKey="Berti C" first="Caterina" last="Berti">Caterina Berti</name></author><author><name sortKey="Rossi, Giuseppe" sort="Rossi, Giuseppe" uniqKey="Rossi G" first="Giuseppe" last="Rossi">Giuseppe Rossi</name></author><author><name sortKey="Bianchi, Maria Cristina" sort="Bianchi, Maria Cristina" uniqKey="Bianchi M" first="Maria Cristina" last="Bianchi">Maria Cristina Bianchi</name></author><author><name sortKey="Tosetti, Michela" sort="Tosetti, Michela" uniqKey="Tosetti M" first="Michela" last="Tosetti">Michela Tosetti</name></author><author><name sortKey="Murri, Luigi" sort="Murri, Luigi" uniqKey="Murri L" first="Luigi" last="Murri">Luigi Murri</name></author><author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7C857B1375773E9FB2A8A78778EDA383AE6D9B10</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21576</idno><idno type="url">https://api.istex.fr/document/7C857B1375773E9FB2A8A78778EDA383AE6D9B10/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001398</idno><idno type="wicri:Area/Istex/Curation">001398</idno><idno type="wicri:Area/Istex/Checkpoint">001906</idno><idno type="wicri:doubleKey">0885-3185:2007:Lucetti C:influences:of:dopaminergic</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:17722082</idno><idno type="wicri:Area/PubMed/Corpus">002537</idno><idno type="wicri:Area/PubMed/Curation">002537</idno><idno type="wicri:Area/PubMed/Checkpoint">002770</idno><idno type="wicri:Area/Ncbi/Merge">001E22</idno><idno type="wicri:Area/Ncbi/Curation">001E22</idno><idno type="wicri:Area/Ncbi/Checkpoint">001E22</idno><idno type="wicri:doubleKey">0885-3185:2007:Lucetti C:influences:of:dopaminergic</idno><idno type="wicri:Area/Main/Merge">003D20</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:08-0071401</idno><idno type="wicri:Area/PascalFrancis/Corpus">001460</idno><idno type="wicri:Area/PascalFrancis/Curation">001859</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001634</idno><idno type="wicri:doubleKey">0885-3185:2007:Lucetti C:influences:of:dopaminergic</idno><idno type="wicri:Area/Main/Merge">004224</idno><idno type="wicri:Area/Main/Curation">002D98</idno><idno type="wicri:Area/Main/Exploration">002D98</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study</title><author><name sortKey="Lucetti, Claudio" sort="Lucetti, Claudio" uniqKey="Lucetti C" first="Claudio" last="Lucetti">Claudio Lucetti</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Del Dotto, Paulo" sort="Del Dotto, Paulo" uniqKey="Del Dotto P" first="Paulo" last="Del Dotto">Paulo Del Dotto</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Neurology Unit, Hospital of Viareggio</wicri:regionArea><wicri:noRegion>Hospital of Viareggio</wicri:noRegion></affiliation></author><author><name sortKey="Gambaccini, Gianna" sort="Gambaccini, Gianna" uniqKey="Gambaccini G" first="Gianna" last="Gambaccini">Gianna Gambaccini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Ceravolo, Roberto" sort="Ceravolo, Roberto" uniqKey="Ceravolo R" first="Roberto" last="Ceravolo">Roberto Ceravolo</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Logi, Chiara" sort="Logi, Chiara" uniqKey="Logi C" first="Chiara" last="Logi">Chiara Logi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Berti, Caterina" sort="Berti, Caterina" uniqKey="Berti C" first="Caterina" last="Berti">Caterina Berti</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Rossi, Giuseppe" sort="Rossi, Giuseppe" uniqKey="Rossi G" first="Giuseppe" last="Rossi">Giuseppe Rossi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Epidemiology and Biostatistics Unit, Institute of Clinical Physiology – CNR Pisa</wicri:regionArea><wicri:noRegion>Institute of Clinical Physiology – CNR Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Bianchi, Maria Cristina" sort="Bianchi, Maria Cristina" uniqKey="Bianchi M" first="Maria Cristina" last="Bianchi">Maria Cristina Bianchi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroradiology, Hospital of Pisa</wicri:regionArea><wicri:noRegion>Hospital of Pisa</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Magnetic Resonance, IRCCS Stella Maris, Pisa</wicri:regionArea><wicri:noRegion>Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Tosetti, Michela" sort="Tosetti, Michela" uniqKey="Tosetti M" first="Michela" last="Tosetti">Michela Tosetti</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Laboratory of Magnetic Resonance, IRCCS Stella Maris, Pisa</wicri:regionArea><wicri:noRegion>Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Murri, Luigi" sort="Murri, Luigi" uniqKey="Murri L" first="Luigi" last="Murri">Luigi Murri</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, University of Pisa</wicri:regionArea><wicri:noRegion>University of Pisa</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-11-15">2007-11-15</date><biblScope unit="vol">22</biblScope><biblScope unit="issue">15</biblScope><biblScope unit="page" from="2170">2170</biblScope><biblScope unit="page" to="2175">2175</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">7C857B1375773E9FB2A8A78778EDA383AE6D9B10</idno><idno type="DOI">10.1002/mds.21576</idno><idno type="ArticleID">MDS21576</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aspartic Acid (analogs & derivatives)</term><term>Aspartic Acid (metabolism)</term><term>Choline (metabolism)</term><term>Creatinine (metabolism)</term><term>Dopamine Agonists (therapeutic use)</term><term>Dopamine agonist</term><term>Female</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Magnetic Resonance Spectroscopy</term><term>Male</term><term>Middle Aged</term><term>Motor Cortex (drug effects)</term><term>Motor Cortex (metabolism)</term><term>Motor Cortex (pathology)</term><term>Motor cortex</term><term>Nervous system diseases</term><term>Nuclear magnetic resonance imaging</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (metabolism)</term><term>Parkinson Disease (pathology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Pergolide</term><term>Pergolide (therapeutic use)</term><term>Protons</term><term>Treatment</term><term>Treatment Outcome</term><term>dopamine agonists</term><term>pergolide</term><term>spectroscopy</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Aspartic Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Aspartic Acid</term><term>Choline</term><term>Creatinine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term><term>Pergolide</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Cortex</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Motor Cortex</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Motor Cortex</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Magnetic Resonance Spectroscopy</term><term>Male</term><term>Middle Aged</term><term>Protons</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cortex moteur</term><term>Imagerie RMN</term><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Pergolide</term><term>Stimulant dopaminergique</term><term>Traitement</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to investigate neurochemical and metabolic changes in the motor cortex in a group of de novo Parkinson's disease (PD) patients before and after 6 mo treatment with the dopamine agonist pergolide. Proton magnetic resonance spectroscopy (1H‐MRS) has been used to study striatal and cortical metabolism in PD and other parkinsonisms. So far, no studies evaluating possible brain metabolic changes in PD patients before and after dopaminergic therapy have been reported. De novo PD patients (11) and controls (11) underwent clinical evaluation (UPDRS‐III motor evaluation) and a first single‐voxel 1H‐MRS of the motor cortex. 1H‐MRS studies were performed using the PROBE‐SV System implemented on a 1.5 Tesla Scanner (GE Medical System, Milwaukee, WI). Pergolide was administered up to a dose of 1 mg t.i.d. After 6 mo follow‐up, all patients were clinically evaluated and a second single‐voxel 1H‐MRS was performed. Lower values of Cho/Cr and NAA/Cr ratios were observed in the motor cortex of PD patients compared with controls (P < 0.02 and P < 0.01, respectively). After 6 mo therapy with pergolide (1 mg t.i.d), PD patients showed an improvement in motor performances (P < 0.05) and an increase in Cho/Cr ratios in the motor cortex at the second 1H‐MRS evaluation (P < 0.05) was reported. In conclusion, cortical NAA/Cr and Cho/Cr ratios may be impaired in de novo PD. Dopaminergic therapy capable of improving motor function may restore the Cho/Cr ratio in the motor cortex. © 2007 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Lucetti, Claudio" sort="Lucetti, Claudio" uniqKey="Lucetti C" first="Claudio" last="Lucetti">Claudio Lucetti</name></noRegion><name sortKey="Berti, Caterina" sort="Berti, Caterina" uniqKey="Berti C" first="Caterina" last="Berti">Caterina Berti</name><name sortKey="Bianchi, Maria Cristina" sort="Bianchi, Maria Cristina" uniqKey="Bianchi M" first="Maria Cristina" last="Bianchi">Maria Cristina Bianchi</name><name sortKey="Bianchi, Maria Cristina" sort="Bianchi, Maria Cristina" uniqKey="Bianchi M" first="Maria Cristina" last="Bianchi">Maria Cristina Bianchi</name><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name><name sortKey="Ceravolo, Roberto" sort="Ceravolo, Roberto" uniqKey="Ceravolo R" first="Roberto" last="Ceravolo">Roberto Ceravolo</name><name sortKey="Del Dotto, Paulo" sort="Del Dotto, Paulo" uniqKey="Del Dotto P" first="Paulo" last="Del Dotto">Paulo Del Dotto</name><name sortKey="Gambaccini, Gianna" sort="Gambaccini, Gianna" uniqKey="Gambaccini G" first="Gianna" last="Gambaccini">Gianna Gambaccini</name><name sortKey="Logi, Chiara" sort="Logi, Chiara" uniqKey="Logi C" first="Chiara" last="Logi">Chiara Logi</name><name sortKey="Murri, Luigi" sort="Murri, Luigi" uniqKey="Murri L" first="Luigi" last="Murri">Luigi Murri</name><name sortKey="Rossi, Giuseppe" sort="Rossi, Giuseppe" uniqKey="Rossi G" first="Giuseppe" last="Rossi">Giuseppe Rossi</name><name sortKey="Tosetti, Michela" sort="Tosetti, Michela" uniqKey="Tosetti M" first="Michela" last="Tosetti">Michela Tosetti</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002D98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:7C857B1375773E9FB2A8A78778EDA383AE6D9B10
|texte= Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study
}}
| This area was generated with Dilib version V0.6.23. |  |